-- 
Edwards Lifesciences, Intel, Rosetta, Vulcan: U.S. Equity Movers

-- B y   L u   W a n g
-- 
2011-12-12T21:23:07Z

-- http://www.bloomberg.com/news/2011-12-11/abb-bp-coca-cola-lockheed-wendy-s-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in New York.  Financial shares retreated as Moody’s Investors Service
said it will review the ratings of all European Union countries.  Bank of America Corp. (BAC)   declined 4.7 percent, the
most in the  Dow Jones Industrial Average , to $5.45.  JPMorgan
Chase & Co. (JPM)   fell 3.4 percent to $32.04.  Morgan Stanley (MS) 
 slipped 6.1 percent to $15.38.  Citigroup Inc. (C)  
dropped 5.4 percent to $27.22.  Cheniere Energy Inc. (LNG)   jumped 5.5 percent to $10.04,
the highest price since Nov. 30. Gail India Ltd. (GAIL IN)
agreed to buy 3.5 million metric tons of liquefied natural gas a
year for two decades from the Houston-based liquefied-natural-
gas company.  Diamond Foods Inc. (DMND)   fell the most since its
initial public offering in July 2005, sliding 23 percent to
$31.30. The snack maker, which is undergoing an internal probe
into whether money paid to walnut growers violated accounting
rules, fell after the Wall Street Journal reported that some
farmers questioned explanations of payments. Paul Kranhold, an
outside spokesman for Diamond, said the payments were
confidential and the company wouldn’t comment further.  Edwards Lifesciences Corp. (EW)   climbed 5.1 percent, the
most since Oct. 20, to $67.85. The maker of products to treat
late-stage cardiovascular disease was raised to “buy” from
“hold” at Canaccord Genuity Corp., which cited a “robust”
product pipeline and a better-than-expected 2012 forecast from
management.  Endo Pharmaceuticals Holdings Inc. (ENDP)   rose 6 percent
to $36.04, the highest price since Aug. 1. The drugmaker said
the U.S.  Food and Drug Administration  approved a new formulation
for its crush-resistant Opana painkiller.  Fuelcell Energy Inc. (FCEL)   jumped 15 percent, the most
since Sept. 7, to $1.09. The maker of low-pollution  power plants 
agreed to partner with Abengoa SA to develop localized
stationary fuel cell power plants for  Europe  and  Latin America .  Intel Corp. (INTC)   dropped the most since Aug. 18,
erasing 4 percent to $24. The world’s largest maker of
semiconductors cut its forecast for fourth-quarter revenue,
saying supply shortages for hard drives are prompting computer
producers to cut orders for other components.  Applied Materials Inc. (AMAT)  , the largest producer of
chipmaking equipment, fell 6.1 percent to $10.52.  Onyx Pharmaceuticals Inc. (ONXX)   tumbled 4 percent, the
most since Nov. 1, to $39. The pharmaceutical company’s
experimental cancer drug carfilzomib will get a standard review
from U.S. regulators, instead of an accelerated process sought
by the company. The Food and Drug Administration said the
company hadn’t conducted the clinical trials necessary for the
quicker review.  Rosetta Resources Inc. (ROSE)   fell 12 percent, the most
since March 2009, to $44.66. The oil and natural gas producer
had its share-price estimate cut to $53 from $55 by Howard Weil
Inc., which said the company’s planned capital spending for next
year is “much higher than we expected.”  Salesforce.com Inc. (CRM)   slipped 6.3 percent, the most
since Nov. 18, to $116.07. The largest maker of online customer-
management software was cut to “underperform” from “neutral”
at Cowen & Co. LLC.  Vulcan Materials Co. (VMC)   rallied 15 percent to $38.70
for the biggest increase in the Standard & Poor’s 500 Index.
 Martin Marietta Materials Inc. (MLM)  , a supplier of crushed
stone, offered to buy the producer of construction aggregates,
asphalt mix and concrete for about $36.69 a share, or $4.7
billion.  To contact the reporters on this story:
 Lu Wang  in  New York  at   lwang8@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 